Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...SMACC Conference
The 105 years since the first successful thoracic oesophagectomy was performed saw initially slow progress in terms of operative mortality, morbidity and oncological outcomes. Even until the late 1990’s, operative mortality figures of 15-20% were commonplace and long term survival was poor, as low as 12%1. The last 20 years has seen a major change in these outcomes both within Australia and overseas. These improvements have been based on the bed rocks of improved surgical techniques, improved peri operative care, changes in the distribution of the pathophysiology of the disease, improved patient selection through better staging, Development of endoscopic techniques for early tumours, development of effective neo adjuvant regimes and the development of “high” volume centres have all contributed to the current figures of 4% preoperative mortality and overall 5 year survivals in the post surgical patient of 40%. Better understanding of the nutritional issues involved has led to an emphasis on better quality of life issues in both the curative and palliative settings. This talk outlines the forces that have brought about the changes including outlining the modern treatment algorithm and discussing the volume effects of surgery in the Australian context
1. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67: 381-90
Factors associated with developing esophageal adenocarcinoma in Barett's esop...Dr Sayan Das
Based on the study “Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett’s esophagus cohort” by Krishnamoorthi R et al published in “HHS Public Access” on 2016 July
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...SMACC Conference
The 105 years since the first successful thoracic oesophagectomy was performed saw initially slow progress in terms of operative mortality, morbidity and oncological outcomes. Even until the late 1990’s, operative mortality figures of 15-20% were commonplace and long term survival was poor, as low as 12%1. The last 20 years has seen a major change in these outcomes both within Australia and overseas. These improvements have been based on the bed rocks of improved surgical techniques, improved peri operative care, changes in the distribution of the pathophysiology of the disease, improved patient selection through better staging, Development of endoscopic techniques for early tumours, development of effective neo adjuvant regimes and the development of “high” volume centres have all contributed to the current figures of 4% preoperative mortality and overall 5 year survivals in the post surgical patient of 40%. Better understanding of the nutritional issues involved has led to an emphasis on better quality of life issues in both the curative and palliative settings. This talk outlines the forces that have brought about the changes including outlining the modern treatment algorithm and discussing the volume effects of surgery in the Australian context
1. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67: 381-90
Factors associated with developing esophageal adenocarcinoma in Barett's esop...Dr Sayan Das
Based on the study “Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett’s esophagus cohort” by Krishnamoorthi R et al published in “HHS Public Access” on 2016 July
Presentazione a cura del Dottor Riccardo Marmo - "HOT TOPICS IN GASTROENTEROLOGIA - I TUMORI DELL'APPARATO DIGERENTE: cosa è cambiato e cosa bisogna sapere" - Roma 10/11/2018
Targeting Telomerase and Topoisomerase-II by Natural Moieties: An Anti-Cancer...CrimsonpublishersCancer
One of the fundamental characteristic of tumor cell is to maintain the telomere length for continues progressive growth and survival. For the same, tumor cell has elevated levels of telomerase enzyme[1]. Telomerase is an unusual enzyme that acts on parts of chromosomes known as telomeres. Telomerase is a ribonucleoprotein and expressed in approximately 85% of different human cancers[2]. There is strong evidence for the existence of an important relationship between telomeres, telomerase and cancer [3]. Normal human cells progressively lose telomeres with each cell division until a few short telomeres become uncapped leading to a growth arrest, known as replicative aging. This phenomenon is totally absent in the cancer and cancer cells are adapted to have higher levels of telomerase enzyme which results in uncontrolled cell division. Attempts have also been made to develop telomere length-and telomerase-based diagnostic tools and anticancer therapeutics [4].
Expanding treatment platform in m crc bayer - asyut 2018Mohamed Abdulla
Describes the different therapeutic approach to patients with metastatic colorectal cancer in the 3rd subsequent treatment line with especial emphasis on the role of regorafenib and how to manipulate the adverse events while not compromise the outcome.
Why You Should Join a Nonprofit Board, by Don ChamberlinDon Chamberlin
Despite the myth, a nonprofit board is open to just about anybody, not just those with lots of money in their pockets. Here are some reasons you shouldn't turn down this chance.
Presentazione a cura del Dottor Riccardo Marmo - "HOT TOPICS IN GASTROENTEROLOGIA - I TUMORI DELL'APPARATO DIGERENTE: cosa è cambiato e cosa bisogna sapere" - Roma 10/11/2018
Targeting Telomerase and Topoisomerase-II by Natural Moieties: An Anti-Cancer...CrimsonpublishersCancer
One of the fundamental characteristic of tumor cell is to maintain the telomere length for continues progressive growth and survival. For the same, tumor cell has elevated levels of telomerase enzyme[1]. Telomerase is an unusual enzyme that acts on parts of chromosomes known as telomeres. Telomerase is a ribonucleoprotein and expressed in approximately 85% of different human cancers[2]. There is strong evidence for the existence of an important relationship between telomeres, telomerase and cancer [3]. Normal human cells progressively lose telomeres with each cell division until a few short telomeres become uncapped leading to a growth arrest, known as replicative aging. This phenomenon is totally absent in the cancer and cancer cells are adapted to have higher levels of telomerase enzyme which results in uncontrolled cell division. Attempts have also been made to develop telomere length-and telomerase-based diagnostic tools and anticancer therapeutics [4].
Expanding treatment platform in m crc bayer - asyut 2018Mohamed Abdulla
Describes the different therapeutic approach to patients with metastatic colorectal cancer in the 3rd subsequent treatment line with especial emphasis on the role of regorafenib and how to manipulate the adverse events while not compromise the outcome.
Why You Should Join a Nonprofit Board, by Don ChamberlinDon Chamberlin
Despite the myth, a nonprofit board is open to just about anybody, not just those with lots of money in their pockets. Here are some reasons you shouldn't turn down this chance.
Maryland summit jhh 2015 how to live longer and better with lupuslupusdmv
Lupus is a chronic disease that people must learn to deal with their entire lives. Dealing with it successfully involves more than just taking medications. There are many important steps the people who have lupus should take in order to have a good quality of life and live longer. Dr. Thomas will discuss these important steps as well as explain why they are important to do on a regular basis.
Classification using Apache SystemML by Prithviraj SenArvind Surve
This deck will cover various algorithms at high level. Those algorithms include "Supervised Learning and Classification", "Training Discriminative Classifiers", "Representer Theorem", "Support Vector Machines", "Logistic Regression", "Generative Classifiers: Naive Bayes", "Deep Learning" and "Tree Ensembles"
Epidemiology./Biostatistics class on lung cancer screening including description of lung cancer, natural history and treatment, lung cancer statistics, lung cancer risk factors, NLST results, NLST follow-on, criteria for a good screening test, USPSTF and CMS lung cancer screening guidelines, and challenges to screening
Presentada en el marco del Primer Simposiso de Cáncer Gastrointestinal - ACHO. Hotel Sonesta, Bogotá, 29.07.2017.
Se corrigen slides 3, 11 y 16; se adiciona slide de metastásico, que se ubica antes de la sección de antiangiogénicos.
1. Page1
RECENT PEER REVIEWED ARTICLES REFERENCE
1: Trovato GM, Tamura K. The lesson of ankle-brachial index for long-term
clinical outcomes: Time is not a line, but a series of now-points.
Atherosclerosis. 2016 Jul;250:186-8. doi: 10.1016/j.atherosclerosis.2016.05.013.
Epub 2016 May 6. PubMed PMID: 27179581.
2: Hahn B, Akita A, Rankin L, Scibilia M, Trovato G, Foley M, Hirschorn D.
Incidence and pathology of repeat CT abdomen and pelvis in an adult emergency
department population. Clin Imaging. 2016 Feb 26;40(5):861-864. doi:
10.1016/j.clinimag.2016.02.020. [Epub ahead of print] PubMed PMID: 27179159.
3: Trovato GM. Clinical research and methodology. The paradigm of fatty liver and
atherosclerosis behind the chicken or the egg dilemma. Atherosclerosis. 2016
Jun;249:228-9. doi: 10.1016/j.atherosclerosis.2016.02.031. Epub 2016 Mar 9.
PubMed PMID: 27012655.
4: Trovato GM, Sperandeo M. Objectively Measuring the Ghost in the Machine:
B-Lines as Uncertain Measures on Which to Base Clinical Assessment. JACC
Cardiovasc Imaging. 2015 Dec;8(12):1470. doi: 10.1016/j.jcmg.2014.12.035. PubMed
PMID: 26699116.
5: Trovato FM, Tognarelli JM, Crossey MM, Catalano D, Taylor-Robinson SD, Trovato
GM. Challenges of liver cancer: Future emerging tools in imaging and urinary
biomarkers. World J Hepatol. 2015 Nov 18;7(26):2664-75. doi:
10.4254/wjh.v7.i26.2664. Review. PubMed PMID: 26609343; PubMed Central PMCID:
PMC4651910. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651910/
6: Rea G, Trovato GM. A Farewell to B-Lines: Ageing and Disappearance of
Ultrasound Artifacts as a Diagnostic Tool. Respiration. 2015;90(6):522. doi:
10.1159/000441010. Epub 2015 Oct 7. PubMed PMID: 26440116.
7: Trovato GM, Catalano D, Sperandeo M. Top or Flop: The Need to Improve
Knowledge and Skills Achieved by Ultrasound Medical Curricula. Acad Med. 2015
Jul;90(7):839-40. doi: 10.1097/ACM.0000000000000745. PubMed PMID: 26414050.
8: Trovato FM, Martines GF, Brischetto D, Catalano D, Musumeci G, Trovato GM.
Fatty liver disease and lifestyle in youngsters: diet, food intake frequency,
exercise, sleep shortage and fashion. Liver Int. 2016 Mar;36(3):427-33. doi:
10.1111/liv.12957. Epub 2015 Sep 28. PubMed PMID: 26346413.
9: Sperandeo M, De Cata A, Molinaro F, Trovato FM, Catalano D, Simeone A,
Varriale A, Martines GF, Trovato G. Ultrasound signs of pulmonary fibrosis in
systemic sclerosis as timely indicators for chest computed tomography. Scand J
Rheumatol. 2015;44(5):389-98. doi: 10.3109/03009742.2015.1011228. Epub 2015 Jun
23. PubMed PMID: 26099251.
10: Trovato GM, Sperandeo M. Pulmonary ultrasonography: staying within the lines
prevents us finding something better on the other side. Chest. 2015
Jun;147(6):e236-7. doi: 10.1378/chest.14-3118. PubMed PMID: 26033146.
11: Trovato GM, Catalano D, Sperandeo M, Graziano P. Artifacts, Noise and
Interference: Much Ado about Ultrasound. Respiration. 2015;90(1):85. doi:
2. Page2
10.1159/000375316. Epub 2015 Mar 20. PubMed PMID: 25824977.
12: Trovato FM, Catalano D, Ragusa A, Martines GF, Pirri C, Buccheri MA, Di Nora
C, Trovato GM. Relationship of MTHFR gene polymorphisms with renal and cardiac
disease. World J Nephrol. 2015 Feb 6;4(1):127-37. doi: 10.5527/wjn.v4.i1.127.
PubMed PMID: 25664255; PubMed Central PMCID: PMC4317623.
13: Trovato GM, Sperandeo M, Catalano D. Ultrasound diagnosis of acute pulmonary
edema: the oblivion of a great future behind us. Acad Emerg Med. 2015
Feb;22(2):244-5. doi: 10.1111/acem.12584. Epub 2015 Jan 29. PubMed PMID:
25640171.
14: Trovato GM, Sperandeo M. The resistible rise of B-line lung ultrasound
artefacts. Respiration. 2015;89(2):175-6. doi: 10.1159/000369037. Epub 2015 Jan
14. PubMed PMID: 25592165.
15: Trovato GM. Simplicity is the ultimate sophistication. PR
electrocardiographic intervals for smart forecasting of decline in renal
function. Atherosclerosis. 2015 Jun;240(2):550-1. doi:
10.1016/j.atherosclerosis.2014.11.001. Epub 2014 Nov 6. PubMed PMID: 25526878.
16: Trovato GM, Catalano D, Sperandeo M. M-mode: a valuable tool in cardiology,
is not yet ready to use in pneumology. Respiration. 2014;88(6):518. doi:
10.1159/000367813. Epub 2014 Nov 12. PubMed PMID: 25402592.
17: Sperandeo M, Dimitri L, Pirri C, Trovato FM, Catalano D, Trovato GM.
Advantages of thoracic ultrasound-guided fine-needle aspiration biopsy in lung
cancer and mesothelioma. Chest. 2014 Nov;146(5):e178-9. doi:
10.1378/chest.14-1557. PubMed PMID: 25367494.
18: Trovato FM, Catalano D, Garozzo A, Martines GF, Pirri C, Trovato GM. ADV36
adipogenic adenovirus in human liver disease. World J Gastroenterol. 2014 Oct
28;20(40):14706-16. doi: 10.3748/wjg.v20.i40.14706. Review. PubMed PMID:
25356033; PubMed Central PMCID: PMC4209536.
19: Trovato GM. Sustainable medical research by effective and comprehensive
medical skills: overcoming the frontiers by predictive, preventive and
personalized medicine. EPMA J. 2014 Aug 27;5(1):14. doi: 10.1186/1878-5085-5-14.
eCollection 2014. PubMed PMID: 25250099; PubMed Central PMCID: PMC4171719.
http://epmajournal.biomedcentral.com/articles/10.1186/1878-5085-5-14
20: Trovato G, Sperandeo M. A picture is worth a thousand words: the need for CT
for assessment of size and distribution of pneumothorax. Intensive Care Med. 2014
Oct;40(10):1614-5. doi: 10.1007/s00134-014-3461-y. Epub 2014 Sep 11. PubMed PMID:
25209129.
21: Sperandeo M, Maggi M, Catalano D, Trovato G. No sliding, no pneumothorax:
thoracic ultrasound is not an all-purpose tool. J Clin Anesth. 2014
Aug;26(5):425-6. doi: 10.1016/j.jclinane.2014.04.005. Epub 2014 Aug 14. PubMed
PMID: 25129558.
22: Trovato G, Sperandeo M, Catalano D. Letter to the editor: Mostbeck G.
3. Page3
Elastography everywhere--now even the lungs! Ultraschall in Med. 2014; 35: 5 - 8.
Ultraschall Med. 2014 Aug;35(4):371; discussion 371-2. doi:
10.1055/s-0034-1366523. Epub 2014 Aug 15. PubMed PMID: 25127226.
23: Trovato GM, Sperandeo M, Catalano D. Thoracic ultrasound: Possible
complementary criteria for the assessment of pulmonary fibrosis. Ann Thorac Med.
2014 Jul;9(3):179. doi: 10.4103/1817-1737.134077. PubMed PMID: 24987479; PubMed
Central PMCID: PMC4073577.
24: Trovato G, Pace P, Martines GF, Brischetto D. Mala-movida: late bed-timing
and wake-up induce malnutrition and underweight in youngsters. Chronobiol Int.
2014 Oct;31(8):945-6. doi: 10.3109/07420528.2014.931414. Epub 2014 Jun 25. PubMed
PMID: 24963991.
25: Sperandeo M, Trovato FM, Dimitri L, Catalano D, Simeone A, Martines GF,
Piscitelli AP, Trovato GM. Lung transthoracic ultrasound elastography imaging and
guided biopsies of subpleural cancer: a preliminary report. Acta Radiol. 2015
Jul;56(7):798-805. doi: 10.1177/0284185114538424. Epub 2014 Jun 20. PubMed PMID:
24951615.
26: Trovato GM, Catalano D, Sperandeo M. Assessment of lung ultrasound artifacts
(B-lines): incremental contribution to echocardiography in heart failure? JACC
Cardiovasc Imaging. 2014 Jun;7(6):635. doi: 10.1016/j.jcmg.2013.11.013. PubMed
PMID: 24925334.
27: Trovato G, Brischetto D, Pace P, Fabio Martines G. Perceived body weight
status of youngsters interferes with headache in obese and non-obese subjects.
Headache. 2014 Jun;54(6):1062-3. doi: 10.1111/head.12374. PubMed PMID: 24916593.
28: Maggi M, Catalano D, Sperandeo M, Trovato G. Comprehensive clinical evidence
for pulmonary embolism diagnosis and workup. Chest. 2014 May;145(5):1173-4. doi:
10.1378/chest.13-2792. PubMed PMID: 24798850.
29: Trovato GM, Catalano D, Sperandeo M. Echocardiographic and lung ultrasound
characteristics in ambulatory patients with dyspnea or prior heart failure.
Echocardiography. 2014 Mar;31(3):406-7. doi: 10.1111/echo.12518. PubMed PMID:
24606228.
30: Trovato FM, Catalano D, Martines GF, Pace P, Trovato GM. Mediterranean diet
and non-alcoholic fatty liver disease: the need of extended and comprehensive
interventions. Clin Nutr. 2015 Feb;34(1):86-8. doi: 10.1016/j.clnu.2014.01.018.
Epub 2014 Jan 31. PubMed PMID: 24529325.
31: Sperandeo M, Rotondo A, Guglielmi G, Catalano D, Feragalli B, Trovato GM.
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: use
and limitations. Radiol Med. 2014 Oct;119(10):729-40. doi:
10.1007/s11547-014-0385-0. Epub 2014 Feb 5. Review. PubMed PMID: 24496592.
32: Catalano D, Trovato GM, Ragusa A, Martines GF, Tonzuso A, Pirri C, Buccheri
MA, Trovato FM. Non-alcoholic fatty liver disease (NAFLD) and MTHFR 1298A > C
gene polymorphism. Eur Rev Med Pharmacol Sci. 2014;18(2):151-9. PubMed PMID:
24488901.
4. Page4
33: Trovato G, Brischetto D, Martines GF. Teens' obesity, noise and sleep
deprivation: a perverse liaison. Let's move beyond "movida". Obesity (Silver
Spring). 2014 May;22(5):1209. doi: 10.1002/oby.20712. Epub 2014 Feb 18. PubMed
PMID: 24470382.
34: Catalano D, Trovato GM, Sperandeo M. Acute heart failure diagnosis by
ultrasound: new achievements and persisting limitations. Am J Emerg Med. 2014
Apr;32(4):384-5. doi: 10.1016/j.ajem.2013.12.026. Epub 2013 Dec 18. PubMed PMID:
24462395.
35: Sperandeo M, Trovato GM, Catalano D. Quantifying B-lines on lung sonography:
insufficient evidence as an objective, constructive, and educational tool. J
Ultrasound Med. 2014 Feb;33(2):362-5. doi: 10.7863/ultra.33.2.362. PubMed PMID:
24449744.
36: Trovato FM, Catalano D, Musumeci G, Trovato GM. 4Ps medicine of the fatty
liver: the research model of predictive, preventive, personalized and
participatory medicine-recommendations for facing obesity, fatty liver and
fibrosis epidemics. EPMA J. 2014 Dec 7;5(1):21. doi: 10.1186/1878-5085-5-21.
eCollection 2014. Review. PubMed PMID: 25937854; PubMed Central PMCID:
PMC4417534. http://epmajournal.biomedcentral.com/articles/10.1186/1878-5085-5-21
37: Trovato GM, Sperandeo M, Catalano D. Optimization of thoracic US guidance for
lung nodule biopsy. Radiology. 2014 Jan;270(1):308. doi: 10.1148/radiol.13131527.
PubMed PMID: 24354382.
38: Trovato G, Vezzani A. On illicit drug policies; methods of evaluation and
comments on recent practices. Curr Drug Abuse Rev. 2013 Jun;6(2):144-51. PubMed
PMID: 24308519.
39: Trovato GM, Catalano D, Martines GF, Pirri C, Trovato FM. Western dietary
pattern and sedentary life: independent effects of diet and physical exercise
intensity on NAFLD. Am J Gastroenterol. 2013 Dec;108(12):1932-3. doi:
10.1038/ajg.2013.356. PubMed PMID: 24300872.
40: Trovato GM, Sperandeo M, Catalano D. Thoracic ultrasound guidance for access
to pleural, peritoneal, and pericardial space. Chest. 2013 Nov;144(5):1735-6.
doi: 10.1378/chest.13-1475. PubMed PMID: 24189876.
41: Catalano D, Trovato G, Sperandeo M, Sacco MC. Lung ultrasound in pediatric
pneumonia. The persistent need of chest X-rays. Pediatr Pulmonol. 2014
Jun;49(6):617-8. doi: 10.1002/ppul.22941. Epub 2013 Oct 31. PubMed PMID:
24178894.
42: Catalano D, Sperandeo M, Trovato G. Re: Caiulo VA, Gargani L, Caiulo S,
Fisicaro A, Moramarco F, Latini G, Picano E. Lung ultrasound in bronchiolitis:
comparison with chest X-ray. Eur J Pediatr. 2011;170: 1427-33. Eur J Pediatr.
2014 Mar;173(3):405. PubMed PMID: 24122072.
43: Catalano D, Trovato FM, Pirri C, Trovato GM. Outpatient diagnosis and
therapeutic units linked with ED referrals: a sustainable quality-centered
approach. Am J Emerg Med. 2013 Nov;31(11):1612. doi: 10.1016/j.ajem.2013.07.008.
5. Page5
Epub 2013 Sep 23. PubMed PMID: 24070979.
44: Trovato GM, Catalano D, Martines GF, Trovato FM. Comment on: Lin et al.
Long-term changes in adiposity and glycemic control are associated with past
adenovirus infection. Diabetes Care 2013;36:701-707. Diabetes Care. 2013
Oct;36(10):e184. doi: 10.2337/dc13-0671. PubMed PMID: 24065857; PubMed Central
PMCID: PMC3781529.
45: Trovato GM, Catalano D, Martines GF, Pace P, Trovato FM. Mediterranean diet:
Relationship with anxiety and depression. Ann Neurol. 2014 Apr;75(4):613. doi:
10.1002/ana.23991. Epub 2014 Apr 2. PubMed PMID: 23929593.
46: Trovato GM, Sperandeo M, Catalano D. Computed tomography screening for lung
cancer. Ann Intern Med. 2013 Jul 16;159(2):155. doi:
10.7326/0003-4819-159-2-201307160-00016. PubMed PMID: 23856687.
47: Trovato GM, Martines GF, Trovato FM, Catalano D. Re: "Relation of the
traditional Mediterranean diet to cerebrovascular disease in a Mediterranean
population". Am J Epidemiol. 2013 Aug 15;178(4):661. doi: 10.1093/aje/kwt125.
Epub 2013 Jun 20. PubMed PMID: 23788673.
48: Trovato GM, Catalano D, Martines GF, Sperandeo M. Is it time to measure lung
water by ultrasound? Intensive Care Med. 2013 Sep;39(9):1662. doi:
10.1007/s00134-013-2965-1. Epub 2013 Jun 6. PubMed PMID: 23740276.
49: Catalano D, Trovato GM, Pace P, Martines GF, Trovato FM. Mediterranean diet
and physical activity: an intervention study. Does olive oil exercise the body
through the mind? Int J Cardiol. 2013 Oct 9;168(4):4408-9. doi:
10.1016/j.ijcard.2013.05.034. Epub 2013 May 26. PubMed PMID: 23714600.
50: Dhurandhar NV, Geurts L, Atkinson RL, Casteilla L, Clement K, Gerard P,
Vijay-Kumar M, Nam JH, Nieuwdorp M, Trovato G, Sørensen TI, Vidal-Puig A, Cani
PD. Harnessing the beneficial properties of adipogenic microbes for improving
human health. Obes Rev. 2013 Sep;14(9):721-35. doi: 10.1111/obr.12045. Epub 2013
May 12. Review. PubMed PMID: 23663746.
51: Trovato GM, Catalano D, Trovato FM. The challenge of obesity: can we look to
the moon instead of the finger? J Am Coll Cardiol. 2013 Sep 10;62(11):1036. doi:
10.1016/j.jacc.2013.03.066. Epub 2013 May 2. PubMed PMID: 23643506.
52: Trovato GM, Sperandeo M. Sounds, ultrasounds, and artifacts: which clinical
role for lung imaging? Am J Respir Crit Care Med. 2013 Apr 1;187(7):780-1. PubMed
PMID: 23540884.
53: Trovato GM, Catalano D, Ragusa A, Martines GF, Tonzuso A, Pirri C, Buccheri
MA, Di Nora C, Trovato FM. Renal insufficiency in non-diabetic subjects:
relationship of MTHFR C677t gene polymorphism and left ventricular hypertrophy.
Ren Fail. 2013;35(5):615-23. doi: 10.3109/0886022X.2013.779895. Epub 2013 Mar 28.
PubMed PMID: 23534584.
54: Trovato GM, Martines GF, Trovato FM, Catalano D. Regular coffee: a magic
bullet or a naked gun? Regular coffee but not espresso drinking is protective
6. Page6
against fibrosis in NAFLD. J Hepatol. 2013 Jun;58(6):1264-5. doi:
10.1016/j.jhep.2013.01.033. Epub 2013 Feb 1. PubMed PMID: 23376892.
55: Trovato GM, Rollo VC, Martines GF, Catalano D, Trovato FM, Sperandeo M.
Thoracic ultrasound in the differential diagnosis of severe dyspnea: a
reappraisal. Int J Cardiol. 2013 Aug 10;167(3):1081-3. doi:
10.1016/j.ijcard.2012.10.057. Epub 2012 Nov 17. PubMed PMID: 23167999.
56: Trovato GM, Pace P, Martines GF, Trovato FM, Pirri C, Catalano D. Stress,
abdominal obesity and intrarenal resistive index in essential hypertension. Clin
Ter. 2012 Jul;163(4):299-305. PubMed PMID: 23007813.
57: Trovato GM, Pace P, Cangemi E, Martines GF, Trovato FM, Catalano D. Gender,
lifestyles, illness perception and stress in stable atrial fibrillation. Clin
Ter. 2012 Jul;163(4):281-6. PubMed PMID: 23007810.
58: Trovato GM. Behavior, nutrition and lifestyle in a comprehensive health and
disease paradigm: skills and knowledge for a predictive, preventive and
personalized medicine. EPMA J. 2012 Mar 22;3(1):8. doi:
10.1007/s13167-012-0141-2. PubMed PMID: 22738244; PubMed Central PMCID:
PMC3384462. http://epmajournal.biomedcentral.com/articles/10.1007/s13167-012-0141-2
59: Trovato GM, Martines GF, Pirri C, Trovato FM, Castro A, Garozzo A, Catalano
D. Obesity-independent association of human adenovirus Ad37 seropositivity with
nonalcoholic fatty liver disease. J Clin Gastroenterol. 2012 Jul;46(6):e46-54.
doi: 10.1097/MCG.0b013e31824b225c. PubMed PMID: 22476041.
60: Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Catalano D. Renal
resistive index and parathyroid hormone relationship with renal function in
nondiabetic patients. Endocr Res. 2012;37(2):47-58. doi:
10.3109/07435800.2011.625513. Epub 2011 Oct 18. PubMed PMID: 22007967.
61: Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, Castro A,
Catalano D. Adenovirus-36 seropositivity enhances effects of nutritional
intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci. 2012
Feb;57(2):535-44. doi: 10.1007/s10620-011-1903-8. Epub 2011 Sep 28. PubMed PMID:
21953137.
62: Catalano D, Trovato GM, Martines GF, Pirri C, Trovato FM. Renal function and
severity of bright liver. Relationship with insulin resistance, intrarenal
resistive index, and glomerular filtration rate. Hepatol Int. 2011
Sep;5(3):822-9. doi: 10.1007/s12072-011-9254-2. Epub 2011 Jan 28. PubMed PMID:
21484130.
63: Trovato GM, Pirri C, Martines GF, Trovato F, Catalano D. Coffee, nutritional
status, and renal artery resistive index. Ren Fail. 2010;32(10):1137-47. doi:
10.3109/0886022X.2010.516853. PubMed PMID: 20954972.
64: Trovato GM, Pace P, Salerno S, Trovato FM, Catalano D. Pain assessment in
fibromyalgia and rheumatoid arthritis: influence of physical activity and illness
perception. Clin Ter. 2010;161(4):335-9. PubMed PMID: 20931156.
7. Page7
65: Trovato GM, Pirri C, Martines GF, Tonzuso A, Trovato F, Catalano D. Lifestyle
interventions, insulin resistance, and renal artery stiffness in essential
hypertension. Clin Exp Hypertens. 2010;32(5):262-9. doi:
10.3109/10641960903265204. PubMed PMID: 20662726.
66: Trovato G, Shikanai M, Ukawa G, Kinoshita J, Murai N, Lee JW, Ishii H,
Takanishi A, Tanoue K, Ieiri S, Konishi K, Hashizume M. Development of a colon
endoscope robot that adjusts its locomotion through the use of reinforcement
learning. Int J Comput Assist Radiol Surg. 2010 Jul;5(4):317-25. doi:
10.1007/s11548-010-0481-0. Epub 2010 May 18. PubMed PMID: 20480247.
67: Trovato GM, Pace P, Tamburino C, Garufi G, Martines GF, Pirri C, Trovato F,
Catalano D. Elective coronary stent patients: preinterventional functional status
and clinical-instrumental assessment. Heart Vessels. 2010 Mar;25(2):82-6. doi:
10.1007/s00380-009-1163-0. Epub 2010 Mar 26. PubMed PMID: 20339967.
68: Catalano D, Martines GF, Tonzuso A, Pirri C, Trovato FM, Trovato GM.
Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis
Sci. 2010 Nov;55(11):3200-6. doi: 10.1007/s10620-010-1143-3. Epub 2010 Feb 18.
PubMed PMID: 20165979.
69: Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C, Trovato
FM, Catalano D. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver
disease. Liver Int. 2010 Feb;30(2):184-90. doi: 10.1111/j.1478-3231.2009.02127.x.
Epub 2009 Oct 13. PubMed PMID: 19840251.
70: Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C, Trovato F,
Catalano D. Human obesity relationship with Ad36 adenovirus and insulin
resistance. Int J Obes (Lond). 2009 Dec;33(12):1402-9. doi: 10.1038/ijo.2009.196.
Epub . PubMed PMID: 19786969.
71: Catalano D, Trovato GM, Spadaro D, Martines GF, Garufi G, Tonzuso A, Grasso
D, Sciacchitano SG. Insulin resistance in postmenopausal women: concurrent
effects of hormone replacement therapy and coffee. Climacteric. 2008
Oct;11(5):373-82. doi: 10.1080/13697130802348728. PubMed PMID: 18781481.
72: Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A. Bright liver,
body composition and insulin resistance changes with nutritional intervention: a
follow-up study. Liver Int. 2008 Nov;28(9):1280-7. doi:
10.1111/j.1478-3231.2008.01742.x. Epub 2008 Apr 23. PubMed PMID: 18435716.